Wound retractor and wound healing in hip replacement surgery for hip arthritis
Compares wound healing and infection with or without a wound retractor in hip replacement.
Key facts
- Who runs it
- University of Miami
- Where
- Miami, United StatesSee the site
- Trial code
- Registry title
- Alexis Retractor in Total Hip Arthroplasty
- Status
- Not yet recruiting
- People taking part
- 202 people, planned
- Starts
- Dec 2026
- Expected to end
- Jan 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Alexis wound retractor
- Standard wound retractor
- Record updated
- 5 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults having a first total hip replacement on one side through the front of the hip. It compares wound healing and infection with and without the Alexis wound retractor.
- Age
- 18 Years and older
- Sex
- All sexes
- Disease stage
- Hip osteoarthritis or hip arthritis needing a first (primary) total hip replacement on one side, done by the direct anterior approach with a lengthwise cut.
- Earlier treatment
- No prior open surgery on the hip being operated. No prior total hip replacement on the other hip.
Main reasons for not taking part
- Prior open surgery on the affected hip
- Prior total hip replacement on the other hip
- Allergy to the standard drugs used in the University of Miami hip replacement protocol
- A strict medical reason not to receive those standard drugs
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patients undergoing primary unilateral longitudinal direct anterior approach total hip arthroplasty
- Patients undergoing primary total hip arthroplasty
Who cannot take part
- Patients with history of prior open surgery on the affected hip
- Patients with history of prior total hip arthroplasty on the contralateral hip
- Patients with allergies or absolute contraindication to standardized drugs administered within the University of Miami protocol for total hip replacement
Where in United States
- University of MiamiMiami, United StatesContact: Natalia Cruz, MDNot yet recruiting
About the trial
What the trial wants to find out
To determine if there is a difference in wound healing and surgical site infection (SSI) rates using the Alexis wound retractor vs. not using it in longitudinal direct anterior approach total hip arthroplasty.
The 2 groups in the trial
- Alexis RetractorTreatment being tested
Subjects in this arm will undergo surgery using the Alexis wound retractor.
Treatment: Alexis wound retractor
- Non-Alexis RetractorExisting treatment, for comparison
Subjects in this arm will undergo surgery using a standard retractor that does not include the Alexis device.
Treatment: Standard wound retractor
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Wound Healing Outcomes With and Without the Alexis Wound Retractor in Direct Anterior Approach Total Hip Arthroplasty
- Plain-language title
- Wound retractor and wound healing in hip replacement surgery for hip arthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 5 February 2026